Publications

A Distinct Intestinal Microenvironmental Profile Is Linked To Bowel Habits in Patients with Irritable Bowel Syndrome C. Iribarren,  B. Ahluwalia,  M.K. Magnusson,  J. Sundin,  O. Savolainen,  A. Ross,  H. Törnblom,  M. Simrén, and L.  Öhman UEG Journal October, 2020 DOI: https://doi.org/10.1177/2050640620927345

Randomised Clinical Trial: Effects of Aloe barbadensis Mill. extract on symptoms, fecal microbiota and fecal metabolite profiles in patients with Irritable Bowel Syndrome. Bani Ahluwalia, Maria K. Magnusson, Lena Böhn, Stine Störsrud, Fredrik Larsson, Otto Savolainen, Alastair Ross, Magnus Simrén*, Lena Öhman*; *Shared senior authorship. Neurogastroenterol Motil. April 2020:e13860. DOI: https://doi.org/10.1111/nmo.13860. 

Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies. Bani Ahluwalia, Luiza Moraes, Maria K. Magnusson & Lena Öhman.  Scandinavian Journal of Gastroenterology. 2018; 53:4, 379-389, DOI: https://doi.org/10.1080/00365521.2018.1447597

Mucosal immune system of the gastrointestinal tract: maintaining balance between the good and the bad. Bani Ahluwalia, Maria K. Magnusson & Lena Öhman. , Scandinavian Journal of Gastroenterology, 2017; 52:11, 1185-1193, DOI: https://doi.org/10.1080/00365521.2017.1349173

Effects of Aloe barbadensis Mill. extract (AVH200®) on human blood T cell activity in vitro. Bani Ahluwalia, Maria K. Magnusson, Stefan Isaksson, Fredrik Larsson, Lena Öhman. J Ethnopharmacol. February 2016; 179:301-309. DOI: https://doi.org/10.1016/j.jep.2016.01.003

A Pilot Study of the Effect of Aloe barbadensis Mill. Extract (AVH200(R)) in Patients with Irritable Bowel Syndrome: a Randomized, Double-Blind, Placebo-Controlled Study. Storsrud S, Ponten I, Simren M. J Gastrointestin Liver Dis. 2015; 24(3):275-280. DOI https://doi.org/10.15403/jgld.2014.1121.243.sst